Dr Vidya R Bethi, MD | |
482 Warfield Blvd, Clarksville, TN 37043-6071 | |
(931) 906-6644 | |
(931) 906-7805 |
Full Name | Dr Vidya R Bethi |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Experience | 37 Years |
Location | 482 Warfield Blvd, Clarksville, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922008440 | NPI | - | NPPES |
3800894 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207LP2900X | Anesthesiology - Pain Medicine | MD0000027336 (Tennessee) | Secondary |
208VP0014X | Pain Medicine - Interventional Pain Medicine | MD0000027336 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Vidya R Bethi, MD 482 Warfield Blvd, Clarksville, TN 37043-6071 Ph: (931) 906-6644 | Dr Vidya R Bethi, MD 482 Warfield Blvd, Clarksville, TN 37043-6071 Ph: (931) 906-6644 |
News Archive
Dr Albert Hofmann, a Swiss chemist, first found the effects of LSD or lysergic acid diethylamide or "acid" on the psyche. It has been 75 years since his invention. Now new research finds deeper understanding of how this psychedelic chemical alters the perception and affects the brain.
The National Operating Committee on Standards for Athletic Equipment issued a warning to athletes and parents of athletes to get the facts about football helmets and concussion protection – and not rely solely on marketing and promotional materials.
Nothing Jenn and Jason learned in parenting class prepared them for the challenges they've faced raising a child prone to violent outbursts.
Salk scientists have identified a unique molecular signature in induced pluripotent stem cells (iPSCs), "reprogrammed" cells that show great promise in regenerative medicine thanks to their ability to generate a range of body tissues.
Patients suffering from acute myeloid leukemia, who require stem cell transplantation as part of their treatment,may now benefit from a new best-in-class process that improves the viability and success of cord blood stem cell transplantation.
› Verified 1 days ago